openPR Logo

Press Releases from Non-Invasive Prenatal Testing (4 total)

Global Non-Invasive Prenatal Testing (NIPT) Market Analysis, Size, Volume, Share …

Researchmoz added Most up-to-date research on "Non-Invasive Prenatal Testing (NIPT) Market (Panorama, Bambni Test, Harmony, MaterniT21 PLUS, NIFTY, PrenaTest, Verifi, VisibiliT, informaSeq, Veracity, IONA Test) - Global Market Analysis, Size, Volume, Share, Growth, Trends and Forecast 2011 - 2021" to its huge collection of research reports. Non-Invasive Prenatal Test (NIPT) are targeted at the detection of certain specific chromosomal aneuploidies from maternal blood sample in pregnant women at high risk for

Global Non-Invasive Prenatal Testing (NIPT) Industry Will Grow Steadily At A CAG …

Researchmoz added Most up-to-date research on "Global Non-Invasive Prenatal Testing Market 2016-2020" to its huge collection of research reports. NIPT is an advanced technology that helps detect fatal chromosomal aneuploidies by analyzing the fetus' cell-free DNA. It also helps diagnose the risks for genetic disorders such as Down, Turner, Klinefelter, and XYY syndromes, which are common sex chromosomal aneuploidies associated with reproductive loss, infertility, and language development delays. Since its introduction

Global Non-Invasive Prenatal Testing (NIPT) Market Will Grow Steadily At A CAGR …

Researchmoz added Most up-to-date research on "Global Non-Invasive Prenatal Testing Market 2016-2020" to its huge collection of research reports. NIPT is an advanced technology that helps detect fatal chromosomal aneuploidies by analyzing the fetus' cell-free DNA. It also helps diagnose the risks for genetic disorders such as Down, Turner, Klinefelter, and XYY syndromes, which are common sex chromosomal aneuploidies associated with reproductive loss, infertility, and language development delays. Since its introduction

Global Non-Invasive Prenatal Testing Market to grow at a CAGR of 17.44% during 2 …

About NIPT NIPT is an advanced technology that helps detect fatal chromosomal aneuploidies by analyzing the fetus' cell-free DNA. It also helps diagnose the risks for genetic disorders such as Down, Turner, Klinefelter, and XYY syndromes, which are common sex chromosomal aneuploidies associated with reproductive loss, infertility, and language development delays. Since its introduction into clinical practice in Hong Kong in 2011, NIPT has rapidly spread across the world. Technavios analysts forecast

Go To Page:   1 2 3 4 5 6 7 8 9 10